These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1620298)

  • 1. Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage.
    Yanamoto H; Kikuchi H; Sato M; Shimizu Y; Yoneda S; Okamoto S
    Neurosurgery; 1992 Mar; 30(3):358-63. PubMed ID: 1620298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage.
    Kaminogo M; Yonekura M; Onizuka M; Yasunaga A; Shibata S
    Neurol Med Chir (Tokyo); 1998 Nov; 38(11):704-8; discussion 708-9. PubMed ID: 9919901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effect of synthetic serine protease inhibitor, FUT-175, on cerebral vasospasm in rabbits.
    Yanamoto H; Kikuchi H; Okamoto S; Nozaki K
    Neurosurgery; 1992 Mar; 30(3):351-6; discussion 356-7. PubMed ID: 1620297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of protease inhibitor and immunosuppressant on cerebral vasospasm after subarachnoid hemorrhage in rabbits.
    Yanamoto H; Kikuchi H; Okamoto S
    Surg Neurol; 1994 Nov; 42(5):382-7. PubMed ID: 7974141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB.
    Zhang Z; Nagata I; Kikuchi H; Xue JH; Sakai N; Sakai H; Yanamoto H
    Stroke; 2001 Jul; 32(7):1665-72. PubMed ID: 11441217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral vasospasm caused by cisternal injection of polystyrene latex beads in rabbits is inhibited by a serine protease inhibitor.
    Yanamoto H; Kikuchi H; Okamoto S; Nozaki K
    Surg Neurol; 1994 Nov; 42(5):374-81. PubMed ID: 7974140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage.
    Tokiyoshi K; Ohnishi T; Nii Y
    Surg Neurol; 1991 Aug; 36(2):112-8. PubMed ID: 1891755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
    Haley EC; Kassell NF; Torner JC
    J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.
    Thomas JE; Rosenwasser RH
    Neurosurgery; 1999 Jan; 44(1):48-57; discussion 57-8. PubMed ID: 9894963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage.
    Flamm ES; Adams HP; Beck DW; Pinto RS; Marler JR; Walker MD; Godersky JC; Loftus CM; Biller J; Boarini DJ
    J Neurosurg; 1988 Mar; 68(3):393-400. PubMed ID: 3343611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
    Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
    J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.
    Lasner TM; Weil RJ; Riina HA; King JT; Zager EL; Raps EC; Flamm ES
    J Neurosurg; 1997 Sep; 87(3):381-4. PubMed ID: 9285602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial.
    Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Nagata I; Kikuchi H; Takemae T; Hidaka H
    J Neurosurg; 1992 Apr; 76(4):571-7. PubMed ID: 1545249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined drug therapy with diltiazem, dextran, and hydrocortisone (DDH therapy) for late cerebral vasospasm after aneurysmal subarachnoid hemorrhage: assessment of efficacy and safety in an open clinical study.
    Kawano T; Kazekawa K; Nakashima S; Kohno H; Tanaka N; Honma T; Kaneko Y; Satoh K
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):513-7. PubMed ID: 8520810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of timing of clot removal on chronic vasospasm in a primate model.
    Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
    J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysms].
    Izawa I; Korosue K; Hamano S; Nagao Y; Tamaki N; Matsumoto S
    No Shinkei Geka; 1988; 16(5 Suppl):487-92. PubMed ID: 3399001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
    Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
    No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between angiographic vasospasm, hematoma, and ischemic brain damage following SAH.
    Graham DI; Macpherson P; Pitts LH
    J Neurosurg; 1983 Aug; 59(2):223-30. PubMed ID: 6864287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.